These observations were confirmed by data showing upregulation of galectin 3 in microglia exposed to Aβ in vitro, in microglia surrounding amyloid plaques in vivo and in specimens from AD patients (Boza-Serrano et al., 2019). This evidence concerns the gene LGALS3 and Alzheimer disease.